Topic: Transactions

Continued impact of Samsung deal pushes Swedish company’s royalty take near $300 million – but executives warn upcoming re-negotiations could produce temporary disruption again

19 October 2021

Co-published - IP transfers in the sector happen for many reasons but one of the primary ones is to create additional value from the assets concerned

18 October 2021

Yangtze Memory Technologies Co, based in Wuhan, is just five years old but has emerged as the country’s memory chip champion

14 October 2021

Transaction marks first outside patent acquisition since company was spun out from Huawei last year

13 October 2021

Saturday Opinion: A memorable two days in the Irish capital showed definitively that face-to-face trumps video and allowed for some detailed debate on key topics

09 October 2021

Merck has struck the biggest life sciences M&A deal of 2021 so far. Here are the four key IP-related takeaways.

07 October 2021

Assignment records show that despite parent company’s vast backing for startups, Softbank Corp and its affiliates have not often come into the possession of significant third-party portfolios

04 October 2021

M&A may be stagnant, but innovators are receiving larger upfront payments for partnership agreements

01 October 2021

Luxshare has pursued Chinese legal challenges and gotten more involved in dealmaking in response to its first serious patent litigation threat, filed in the US last year

30 September 2021

Experts embrace the Leahy/Tillis bill’s aims, but warn it could create unwelcome, new overhead costs and administrative burdens

29 September 2021